The US Food and Drug Administration (FDA) has approved the biologics license application for a subcutaneous formulation of ...

The FDA has approved Leqembi Iqlik, a subcutaneous, autoinjector formulation for maintenance dosing in people with early Alzheimer's disease ...

The performance of ARS Pharmaceuticals’ Neffy marginally outpaced historical reports of epinephrine injection effectiveness.

EGRIFTA WR™offers convenience of weekly reconstitution and reduced daily injection volume, compared to EGRIFTA SV® ...

Ashvattha Therapeutics reveals phase 2 results for migaldendranib, showing significant vision improvements and reduced ...

Alphamab Oncology (Stock Code: 9966.HK) announced that the New Drug Application (NDA) for anbenitamab injection (KN026), independently developed by the Company and co-developed with JMT-Bio Technology ...

French pharmaceutical giant Sanofi announced recently that its Tzield has been approved by China's National Medical Products ...